Cognition Therapeutics Inc (CGTX) insider trading
Every open-market stock purchase and sale by Cognition Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: John Brendan Doyle (CFO), $11.3K, 6 months ago.
Last 12 months: insiders bought $32.5K (3 buys) and sold $0 (0 sales).
Recent CGTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | Jack A. Khattar (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Peggy Wallace (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Ellen B Richstone (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Aaron G.L. Fletcher (10% owner) | Bought (not open market) | — |
| Jun 17, 2026 | Brett P Monia (Director) | Bought (not open market) | — |
| May 1, 2026 | John Brendan Doyle (CFO) | Sold (not open market) | $11K |
| Apr 16, 2026 | John Brendan Doyle (CFO) | Bought | $11.3K |
| Apr 16, 2026 | Anthony Caggiano (C-suite exec) | Bought | $11.1K |
| Apr 16, 2026 | Lisa Ricciardi (CEO) | Bought | $10.1K |
| Feb 15, 2026 | Lisa Ricciardi (CEO) | Sold (not open market) | $6.6K |
| Feb 15, 2026 | Anthony Caggiano (C-suite exec) | Sold (not open market) | $5.2K |
| Feb 15, 2026 | John Brendan Doyle (CFO) | Sold (not open market) | $1.7K |
| Feb 4, 2026 | Lisa Ricciardi (CEO) | Sold (not open market) | $53.3K |
| Feb 4, 2026 | John Brendan Doyle (CFO) | Sold (not open market) | $27.7K |
| Feb 4, 2026 | Anthony Caggiano (C-suite exec) | Sold (not open market) | $27.7K |
| Feb 3, 2026 | Lisa Ricciardi (CEO) | Sold (not open market) | $29.2K |
| Feb 3, 2026 | Anthony Caggiano (C-suite exec) | Sold (not open market) | $12.9K |
| Feb 3, 2026 | Anthony Caggiano (C-suite exec) | Bought (not open market) | — |
| Feb 3, 2026 | John Brendan Doyle (CFO) | Bought (not open market) | — |
| Feb 3, 2026 | Lisa Ricciardi (CEO) | Bought (not open market) | — |
| Dec 18, 2025 | Lisa Ricciardi (CEO) | Sold (not open market) | $35.1K |
| Dec 18, 2025 | Anthony Caggiano (C-suite exec) | Sold (not open market) | $30.4K |
| Dec 18, 2025 | John Brendan Doyle (CFO) | Sold (not open market) | $14K |
| Dec 18, 2025 | Anthony Caggiano (C-suite exec) | Bought (not open market) | — |
| Dec 18, 2025 | John Brendan Doyle (CFO) | Bought (not open market) | — |
Who's trading CGTX
- Ellen B Richstone, Director: other filings, last Jun 17, 2026
- Aaron G.L. Fletcher, 10% owner: other filings, last Jun 17, 2026
- Jack A. Khattar, Director: other filings, last Jun 17, 2026
- Peggy Wallace, Director: other filings, last Jun 17, 2026
- Brett P Monia, Director: other filings, last Jun 17, 2026
- John Brendan Doyle, CFO: bought $11.3K (1 buy), last May 1, 2026
- Anthony Caggiano, C-suite exec: bought $11.1K (1 buy), last Apr 16, 2026
- Lisa Ricciardi, CEO: bought $10.1K (1 buy), last Apr 16, 2026
Get free alerts when an insider at Cognition Therapeutics Inc files a new trade →